SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending ahead of its pivotal Phase 3 superiority trial results for Axpaxli in wet AMD, set for release Tuesday, with the community highly optimistic about a potential "landslide victory" and a significant short squeeze amidst circulating rumors of a sweetened acquisition offer from Sanofi.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corp ($BULL) is currently a battleground for investors, with widespread frustration over its sustained price decline and perceived lack of management communication, while a segment of the community sees it as a deeply undervalued long-term opportunity, highlighted by recent institutional filings and a new market data feed for overnight trading.

Pull your BankrWallet out of the Terminal and into the browser to use with Any Dapp, just like Metamask!

BankrWallet

BNKRW is trending with high community interest and volume, driven by the launch of its open-source BankrWallet browser extension, which offers MetaMask-like functionality within the Coinbase BASE ecosystem. Investors are actively discussing its significant upside potential as they anticipate upcoming developer catalysts.

Corsair Gaming, Inc. designs and supplies hardware components for personal computers. It operates through the Gamer and Creator Peripherals, and Gaming Components and Systems segments. The Gamer and Creator Peripherals segment offers gaming keyboards, mice, headsets, controllers, and gaming gear including capture cards, Stream Decks, USB microphones, studio accessories, and EpocCam software, as well as coaching and training services. The Gaming Components and Systems segment focuses on creating power supply units, or PSUs, cooling solutions, computer cases, DRAM modules, prebuilt, and custom-built gaming PCs. The company was founded by Andrew J. Paul in 1994 and is headquartered in Milpitas, CA.

Corsair Gaming Inc

Corsair Gaming is rallying after reporting strong Q4 earnings and announcing a $50 million share repurchase program, further supported by strategic tailwinds from rising RAM prices and a competitor exiting the retail memory market. The community is actively discussing its potential for a short squeeze and highlighting the stock's perceived undervaluation.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as community excitement surges following Conditional Marketing Authorisation for ANKTIVA in Europe, coupled with high anticipation for broader approvals and substantial investment from a strategic Saudi-USA Biotech Alliance, igniting strong anti-short sentiment.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amidst heightened volatility and polarized sentiment, as community concerns over housing affordability, the disruptive economic impact of AI, and geopolitical tensions in the Middle East fuel a contentious debate between those expecting further downside and contrarians anticipating a rebound.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

iShares Russell 2000 ETF

Softer-than-expected CPI data has spurred a strong rally in small-cap stocks, driving discussions around sustained rotation into the IWM. While some in the community anticipate further upside, others caution about overextended valuations, a potential "bull trap," and significant institutional hedging.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is a major talking point as investors eagerly await a 'transformational' acquisition, heavily rumored following CEO Ryan Cohen's cryptic hints and recent reports of notable investors like Michael Burry increasing their positions. The community remains focused on potential market-altering moves and persistent claims of short seller vulnerability, maintaining a strong 'diamond hands' sentiment.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending amid heightened community debate, with many predicting a deeper correction for large-cap tech as AI disruption fears intensify
including a major AI firm being designated a "supply chain risk"
while others suggest current valuations are oversold and poised for a rebound. Traders are closely watching key technical support levels and upcoming economic catalysts that could define the market's next move.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings is trending as activist investor Elliott Management reveals a significant stake, fueling community discussion about potential changes and the recent CEO transition, while many question controversial analyst downgrades for a stock that has lagged its cruise sector rivals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IDEAYA Biosciences (IDYA) Expected to Announce Quarterly Earnings on Thursday

IDEAYA Biosciences (NASDAQ:IDYA) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 12. (View Earnings Report at...

IDEAYA Biosciences, Inc. $IDYA Shares Acquired by New York State Common Retirement Fund

New York State Common Retirement Fund lifted its position in shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 21.7% in the 3rd quarter, according to the company in its most recent...

Knights of Columbus Asset Advisors LLC Invests $934,000 in IDEAYA Biosciences, Inc. $IDYA

Knights of Columbus Asset Advisors LLC bought a new stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) during the third quarter, according to the company in its most recent Form 13F filing...

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH SAN...

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seventeen analysts that are covering the company, Marketbeat Ratings...

IDEAYA Biosciences, Inc. $IDYA Stake Lifted by SG Americas Securities LLC

SG Americas Securities LLC boosted its stake in IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Free Report) by 169.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities...

Day One Biopharmaceuticals (DAWN) Surges 26.7%: Is This an Indication of Further Gains?

Day One Biopharmaceuticals (DAWN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

IDYA March 20th Options Begin Trading

Investors in IDEAYA Biosciences Inc (Symbol: IDYA) saw new options begin trading today, for the March 20th expiration. One of the key inputs that goes into the price an option buyer is willing to...

IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference

IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference IDEAYA Biosciences Announces Participation at the 44th Annual J.P. Morgan Healthcare Conference PR...

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of IDEAYA Biosciences, Inc. (NASDAQ:IDYA - Get Free Report) have earned a consensus rating of "Moderate Buy" from the sixteen analysts that are covering the firm, Marketbeat.com reports. One...

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Ideaya Biosciences Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.95	--	--	N/A
Q3 '25	-$0.83	$1.47	277.36%	BEAT
Q2 '25	-$0.78	-$0.88	-12.56%	MISSED
Q1 '25	-$0.66	-$0.82	-24.03%	MISSED
Q4 '24	-$0.63	-$1.49	-136.97%	MISSED

IDYA
Ideaya Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest IDYA News

IDYAIdeaya Biosciences Inc